SY-5933
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SY-5933, covering 2025-05-14 to 2025-05-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of SY-5933 Plus CT-707 in Advanced Solid Tumors With KRAS p.G12C Mutation [Phase 1, Phase 2]